中国医学装备
中國醫學裝備
중국의학장비
CHINA MEDICAL EQUIPMENT
2014年
1期
89-91
,共3页
王成%邹跃%孙松韦%陈星宇
王成%鄒躍%孫鬆韋%陳星宇
왕성%추약%손송위%진성우
脑转移%颅外转移%放射治疗%预后
腦轉移%顱外轉移%放射治療%預後
뇌전이%로외전이%방사치료%예후
Brain metastasis%Extracranial metastases%Radiotherapy%Prognosis
目的:分析总结脑转移伴颅外转移患者颅内、颅外多部位放疗的作用,探讨多部位放疗在颅内、颅外多发转移患者治疗中的作用以及与预后的关系。方法:选择第二炮兵总医院2007年7月至2011年10月收治的79例脑转移伴颅外多发转移患者的临床资料进行回顾性分析,所有患者均给予全脑放疗(WBRT),且在放疗前或放疗后6个月内新发颅外转移灶。52例患者加用立体定向放射治疗(SRS),其中45例接受颅外转移灶的放射治疗。结果:随访率为97.5%,全组患者中位生存期(MST)为7个月,而单纯颅内放疗组,颅内、颅外多部位放疗组的MST分别为4个月、10个月,两组患者12个月的生存率分别为3%和35%,差异有统计学意义(x2=19.419,P<0.001)。结论:颅内、颅外多部位多次放疗是脑转移颅外多发转移患者一种有效的治疗手段。
目的:分析總結腦轉移伴顱外轉移患者顱內、顱外多部位放療的作用,探討多部位放療在顱內、顱外多髮轉移患者治療中的作用以及與預後的關繫。方法:選擇第二砲兵總醫院2007年7月至2011年10月收治的79例腦轉移伴顱外多髮轉移患者的臨床資料進行迴顧性分析,所有患者均給予全腦放療(WBRT),且在放療前或放療後6箇月內新髮顱外轉移竈。52例患者加用立體定嚮放射治療(SRS),其中45例接受顱外轉移竈的放射治療。結果:隨訪率為97.5%,全組患者中位生存期(MST)為7箇月,而單純顱內放療組,顱內、顱外多部位放療組的MST分彆為4箇月、10箇月,兩組患者12箇月的生存率分彆為3%和35%,差異有統計學意義(x2=19.419,P<0.001)。結論:顱內、顱外多部位多次放療是腦轉移顱外多髮轉移患者一種有效的治療手段。
목적:분석총결뇌전이반로외전이환자로내、로외다부위방료적작용,탐토다부위방료재로내、로외다발전이환자치료중적작용이급여예후적관계。방법:선택제이포병총의원2007년7월지2011년10월수치적79례뇌전이반로외다발전이환자적림상자료진행회고성분석,소유환자균급여전뇌방료(WBRT),차재방료전혹방료후6개월내신발로외전이조。52례환자가용입체정향방사치료(SRS),기중45례접수로외전이조적방사치료。결과:수방솔위97.5%,전조환자중위생존기(MST)위7개월,이단순로내방료조,로내、로외다부위방료조적MST분별위4개월、10개월,량조환자12개월적생존솔분별위3%화35%,차이유통계학의의(x2=19.419,P<0.001)。결론:로내、로외다부위다차방료시뇌전이로외다발전이환자일충유효적치료수단。
Objective: To summarize the effect of radiotherapy in the treatment of the brain and extracranial metastases in patients. Analyze and explore the effect of intracranial and extracranial much place radiotherapy in the treatment of patients with brain and extracranial metastases and the relationship between the radiotherapy and prognosis. Methods:From 2007 to 2011,totally 79 patients with brain and extracranial metastases were treated in our center. All patients were given the whole brain radiotherapy (WBRT), WBRT in before or after 6 months new hair extracranial metastases, 52 people were added stereotactic radiotherapy(γ knife). In 45 cases accepted radiotherapy of extracranial metastases. Results: The following-up rate was 97.5%,The median overall survival time was 7 months for the whole group, The median survival time of Simple intracranial radiotherapy group or intracranial extracranial much place radiotherapy group was 4 months or 10 months, x2=19.419, P<0.001, 12 month survival rates respectively was 3%and 35%. Conclusion:Intracranial and extracranial much place radiotherapy is a effectively treatment for patients with brain and extracranial metastases.